Structure-based discovery of inhibitors of the SARS-CoV-2 Nsp14 N7 -methyltransferase
Preprint
Abstract
An under-explored target for SARS-CoV-2 is non-structural protein 14 (Nsp14), a crucial enzyme for viral replication that catalyzes the methylation of N7 -guanosine of the viral RNA at 5′-end; this enables the virus to evade the host immune response by mimicking the eukaryotic post-transcriptional modification mechanism. We sought new inhibitors of the S-adenosyl methionine (SAM)-dependent methyltransferase (MTase) activity of Nsp14 with three large library docking strategies. First, up to 1.1 billion make-on-demand (“tangible”) lead-like molecules were docked against the enzyme’s SAM site, seeking reversible inhibitors. On de novo synthesis and testing, three inhibitors emerged with IC 50 values ranging from 6 to 43 μM, each with novel chemotypes. Structure-guided optimization and in vitro characterization supported their non-covalent mechanism. In a second strategy, docking a library of 16 million tangible fragments revealed nine new inhibitors with IC 50 values ranging from 12 to 341 μM and ligand efficiencies from 0.29 to 0.42. In a third strategy, a newly created library of 25 million tangible, virtual electrophiles were docked to covalently modify Cys387 in the SAM binding site. Seven inhibitors emerged with IC 50 values ranging from 3.2 to 39 μM, the most potent being a reversible aldehyde. Initial optimization of a second series yielded a 7 μM acrylamide inhibitor. Three inhibitors characteristic of the new series were tested for selectivity against 30 human protein and RNA MTases, with one showing partial selectivity and one showing high selectivity. Overall, 32 inhibitors encompassing eleven chemotypes had IC 50 values 50 values <10 μM. These molecules are among the first non-SAM-like inhibitors of Nsp14, providing multiple starting points for optimizing towards antiviral activity.Keywords
This publication has 81 references indexed in Scilit:
- Ligand Pose and Orientational Sampling in Molecular DockingPLOS ONE, 2013
- Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better BenchmarkingJournal of Medicinal Chemistry, 2012
- RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complexProceedings of the National Academy of Sciences, 2012
- Antiviral drugs against hepatitis C virusGenetic Vaccines and Therapy, 2011
- In Vitro Reconstitution of SARS-Coronavirus mRNA Cap MethylationPLOS Pathogens, 2010
- Effects of a novel arginine methyltransferase inhibitor on T‐helper cell cytokine productionThe FEBS Journal, 2010
- Docking for fragment inhibitors of AmpC β-lactamaseProceedings of the National Academy of Sciences, 2009
- Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferaseProceedings of the National Academy of Sciences, 2009
- Screening in a spirit haunted worldDrug Discovery Today, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004